Hyderabad Paediatrician Resigns and Launches Petition Against Misleading ORS-Like Drink Marketing
In a significant development from Hyderabad, paediatrician Dr Sivaranjani Santosh has taken a bold stand against what she describes as potentially dangerous marketing practices in the pharmaceutical industry. Following her resignation from the Indian Academy of Paediatrics (IAP), Dr Santosh has initiated an online petition that raises serious concerns about sugar-based drinks that closely resemble oral rehydration salts (ORS) in their branding and presentation.
The Petition: Clear Communication for Electrolyte Drinks
The petition, hosted on change.org under the title 'Clear Communication for Electrolyte Drinks: Protect Consumers in Pharmacies', seeks to mobilize public support for stricter regulations. Dr Santosh is specifically calling upon the Food Safety and Standards Authority of India (FSSAI) and the Union health ministry to implement more rigorous guidelines against what she terms misleading branding by pharmaceutical companies.
"The core issue isn't about the safety of sugar-based drinks themselves," Dr Santosh emphasized during our conversation. "Rather, it's about how these products are presented to consumers, particularly in pharmacy settings where people make critical health decisions under pressure."
The Confusion Risk in Medical Emergencies
Dr Santosh warned that branding practices using names similar to ORS, such as "ORSL" or its various rebranded variants, can create dangerous confusion. This is especially concerning during high-pressure situations like medical emergencies when parents or caregivers need to make quick decisions.
"Parents often rely on familiar labels and visual cues when purchasing from pharmacies," she explained. "When sugar-based drinks use packaging and names that closely resemble medically approved ORS, it can lead to mistaken purchases. Using these drinks as substitutes for genuine ORS in cases of dehydration can have serious health consequences."
Broader Public Health Implications
The petition highlights that these marketing strategies risk undermining broader public health efforts by blurring the crucial distinction between medically approved ORS and commercial beverages. ORS, which follows World Health Organisation (WHO) standards, is a scientifically formulated electrolyte solution specifically designed to treat dehydration, particularly in children.
Dr Santosh's initiative comes amid ongoing controversy surrounding rebranded electrolyte drinks in the Indian market. This follows regulatory action by the FSSAI, which earlier barred the use of the 'ORS' label on beverages that do not meet WHO standards for electrolyte composition.
Institutional Challenges and Legal Pressure
Dr Santosh recently resigned from her position with the Indian Academy of Paediatrics, citing what she described as a lack of institutional support. This decision came after she faced legal notices from pharmaceutical firms regarding her public stance on this issue.
The paediatrician's petition represents a growing concern among medical professionals about the intersection of commercial interests and public health. As the petition gains momentum, it raises important questions about:
- Consumer protection in pharmacy settings
- The responsibility of pharmaceutical companies in product branding
- Regulatory oversight of health-related products
- The role of medical professionals in advocating for patient safety
This development underscores the ongoing tension between commercial marketing practices and public health priorities in India's healthcare landscape. As regulatory bodies consider these concerns, the outcome could have significant implications for how health-related products are marketed and sold across the country.
